Makale
Tam Makale
Uluslararası
2020
Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?
TURKISH JOURNAL OF MEDICAL SCIENCES
Cilt 50 · Sayı 4 · ss. 963–968 · 23.06.2020
Özet
Background/aim: Pulmonary embolism (PE) is associated with high morbidity and mortality rates if not diagnosed and treated rapidly. The aim of our study was to investigate the relationship between levels of hypoxia-induced factor-1 alpha (HIF-1 alpha) and clinical course and prognosis in patients with intermediate low-risk, intermediate high-risk, and high-risk PE.
Anahtar kelimeler
hypoxia
Pulmonary thromboembolism
HIF-1 alpha
Atıf için künye
Kerget, B., Afşin, D., Aksakal, A., Aksakal, A., Aşkın, S., & Araz, Ö. (2020). Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism? TURKISH JOURNAL OF MEDICAL SCIENCES, 50(4), 963–968. https://doi.org/10.3906/sag-1908-93
BibTeX
@article{kerget2020-302153,
author = {Kerget, Buğra and Afşin, DE and Aksakal, A and Aksakal, Alperen and Aşkın, Seda and Araz, Ö},
title = {Could HIF-1α be a novel biomarker for the clinical course and treatment of pulmonary embolism?},
journal = {TURKISH JOURNAL OF MEDICAL SCIENCES},
year = {2020},
volume = {50},
number = {4},
pages = {963--968},
issn = {1300-0144},
doi = {10.3906/sag-1908-93},
url = {https://akademik.atauni.edu.tr/yayinlar/302153-could-hif-1a-be-a-novel-biomarker-for-the-clinical-course-and-treatment-of}
}